Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea
· Delayed Price · Currency is KRW 14,600
+90 (0.62%)
Apr 29, 2026, 3:30 PM KST
Hyundai Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,400,230 | 476,821 | 561,851 | 1,038,982 | 1,087,244 | 976,101 | Upgrade
|
| Market Cap Growth | 180.65% | -15.13% | -45.92% | -4.44% | 11.39% | -6.92% | Upgrade
|
| Enterprise Value | 1,377,938 | 447,462 | 579,143 | 1,031,571 | 1,069,527 | 969,321 | Upgrade
|
| Last Close Price | 14510.00 | 4965.00 | 7055.00 | 12295.97 | 12908.41 | 11895.53 | Upgrade
|
| PS Ratio | 398.09 | 135.56 | 37.33 | 109.58 | 138.48 | 105.62 | Upgrade
|
| PB Ratio | 12.65 | 4.31 | 14.25 | 22.95 | 18.67 | 15.85 | Upgrade
|
| P/TBV Ratio | 23.91 | 8.14 | 89.63 | 73.68 | 43.38 | 34.98 | Upgrade
|
| P/FCF Ratio | - | - | 269.15 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 248.93 | - | - | - | Upgrade
|
| EV/Sales Ratio | - | 127.22 | 38.48 | 108.80 | 136.22 | 104.89 | Upgrade
|
| EV/EBITDA Ratio | - | - | 394.62 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 694.59 | - | - | - | Upgrade
|
| EV/FCF Ratio | -75.53 | - | 277.44 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.16 | 0.67 | 0.12 | 0.11 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 18.12 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 12.74 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.20 | 0.58 | -0.14 | -0.21 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.32 | 1.32 | 15.63 | 0.75 | 0.51 | 1.02 | Upgrade
|
| Net Debt / FCF Ratio | 1.22 | 1.22 | 10.99 | 0.96 | 0.69 | 1.57 | Upgrade
|
| Asset Turnover | 0.04 | 0.04 | 0.25 | 0.16 | 0.11 | 0.11 | Upgrade
|
| Inventory Turnover | 3.18 | 3.18 | 1.78 | 1.62 | 1.63 | 1.59 | Upgrade
|
| Quick Ratio | 2.18 | 2.18 | 0.14 | 1.77 | 2.23 | 1.73 | Upgrade
|
| Current Ratio | 2.25 | 2.25 | 0.25 | 2.18 | 2.67 | 2.02 | Upgrade
|
| Return on Equity (ROE) | -29.45% | -29.45% | -16.26% | -28.02% | -26.39% | -35.21% | Upgrade
|
| Return on Assets (ROA) | -11.44% | -11.44% | 0.86% | -10.20% | -22.24% | -6.66% | Upgrade
|
| Return on Invested Capital (ROIC) | -21.45% | -24.09% | 1.65% | -23.13% | -52.30% | -14.85% | Upgrade
|
| Return on Capital Employed (ROCE) | -16.30% | -16.30% | 2.10% | -21.40% | -45.10% | -14.70% | Upgrade
|
| Earnings Yield | -1.58% | -4.64% | -1.23% | -1.40% | -1.45% | -2.05% | Upgrade
|
| FCF Yield | -1.30% | -3.83% | 0.37% | -0.63% | -1.66% | -0.44% | Upgrade
|
| Buyback Yield / Dilution | -721.14% | -721.14% | -16030.92% | -1.04% | -6.64% | -2.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.